These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3909329)

  • 21. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
    Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
    Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of aztreonam in healthy recipients and patients: a review.
    Swabb EA
    Rev Infect Dis; 1985; 7 Suppl 4():S605-12. PubMed ID: 3909317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
    Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
    J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Brogden RN; Heel RC
    Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and pharmacokinetic evaluations of aztreonam in children].
    Meguro H; Arimasu O; Sugamata K; Hiruma F; Sohda H; Shiraishi H; Fujii R
    Jpn J Antibiot; 1985 Nov; 38(11):3217-29. PubMed ID: 4094055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of aztreonam.
    Mattie H
    Clin Pharmacokinet; 1988 Mar; 14(3):148-55. PubMed ID: 3286083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aztreonam versus tobramycin in acute pyelonephritis. A comparative study].
    Gallego J; Jiménez Cruz JF; Gobernado M; Llopis B; Vidal J; Server G; Ruiz JL; David Vera C
    Arch Esp Urol; 1989 Mar; 42(2):116-9. PubMed ID: 2660754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic evaluations and analysis of aztreonam in children].
    Kawasaki H
    Jpn J Antibiot; 1989 Jun; 42(6):1271-8. PubMed ID: 2795851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacterial infections in cancer patients without neutropenia. Comparison between 2 antibiotic combinations (aztreonam and oxacillin versus cefoxitin and tobramycin)].
    Apice G; Beneduce G; Bruni GS; D'Aprile M; Perna M; Silvestro P; Villari P; Pergola M
    Clin Ter; 1989 Nov; 131(3):177-82. PubMed ID: 2533029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
    Bauer LA; Piecoro JJ; Wilson HD; Blouin RA
    Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis.
    Ariza J; Gudiol F; Dolz C; Xiol J; Liñares J; Bosch J; Pallares R
    Hepatology; 1986; 6(5):906-10. PubMed ID: 3530945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and clinical evaluation of aztreonam in pediatrics].
    Ido M; Ihara T; Kamiya H; Sakurai M
    Jpn J Antibiot; 1985 Nov; 38(11):3294-9. PubMed ID: 4094061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group].
    Matsuda S; Oh K; Hirayama H; Shimizu T; Sengoku K; Haga H; Inoue R; Yamazaki T; Mizoguchi H; Tori-i Y
    Jpn J Antibiot; 1990 Apr; 43(4):736-53. PubMed ID: 2199691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aztreonam in the treatment of serious gram-negative infections in the elderly.
    Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased hepatic clearance of clindamycin in critically ill patients with sepsis.
    Mann HJ; Townsend RJ; Fuhs DW; Cerra FB
    Clin Pharm; 1987 Feb; 6(2):154-9. PubMed ID: 3665368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Laboratory and clinical studies on aztreonam in the pediatric field].
    Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1985 Nov; 38(11):3343-8. PubMed ID: 4094067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of aztreonam and imipenem in critically ill patients with pneumonia.
    McKindley DS; Boucher BA; Hess MM; Croce MA; Fabian TC
    Pharmacotherapy; 1996; 16(5):924-31. PubMed ID: 8888088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.